Niraparib
CAS 1038915-60-4
In Stock
Niraparib
Cat. No. STUB-API-NIRAPARIBCAS 1038915-60-4In Stock
Technical Data
Cat. No.STUB-API-NIRAPARIB
CAS1038915-60-4
Mol. FormulaC19H20N4O
Mol. Weight320.396 g/mol
IUPAC2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide
SMILESC1C[C@H](CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N
InChIInChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1
InChI KeyPCHKPVIQAHNQLW-CQSZACIVSA-N
Purity—
Description
Overview
Niraparib, sold under the brand name Zejula, is an anti-cancer medication used for the treatment of epithelial ovarian, fallopian tube, or primary peritoneal cancer. It is taken by mouth. It is a PARP inhibitor
Anant Labs manufacture and furnish high quality Niraparib impurities for global markets. Our Niraparib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.
Synonyms
Niraparib1038915-60-4MK48272-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamideHMC2H89N35ZL-2306JNJ-64091742CHEBI:176844DTXSID50146129
